Valuation Akeso, Inc.

Equities

Market Closed - Hong Kong S.E. Other stock markets 01:38:03 12/05/2026 pm IST			5-day change	1st Jan Change
130.00 ^HKD	-0.99%		+1.72%	+15.04%

28/04	Biodlink International Company Limited Announces Board and Board Committee Changes, Effective from 29 April 2026	CI
28/04	Akeso, Inc. Secures Multiple Authoritative Updates And Upgrades For Ivonescimab In The 2026 CSCO NSCLC Guideline	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	22,632	31,991	35,423	51,197	93,537	1,03,892	-	-
Change	-	41.35%	10.73%	44.53%	82.7%	11.07%	-	-
Enterprise Value (EV) ¹	20,839	31,765	36,849	52,223	89,255	98,370	97,261	91,658
Change	-	52.43%	16%	41.72%	70.91%	10.21%	-1.13%	-5.76%
P/E ratio	-21x	-26.8x	17.4x	-95.1x	-82.6x	809x	73.2x	38.3x
PBR	7.16x	11.9x	7.52x	7.12x	10.2x	11.7x	9.57x	7.2x
PEG	-	-3.54x	-0x	1x	-1x	-7x	0x	0.4x
Capitalization / Revenue	100x	38.2x	7.83x	24.1x	30.6x	20.1x	13.6x	9.52x
EV / Revenue	92.4x	37.9x	8.14x	24.6x	29.2x	19.1x	12.7x	8.4x
EV / EBITDA	-16x	-25.9x	16.8x	-143x	-139x	104x	46.8x	21.1x
EV / EBIT	-15.4x	-23.9x	18x	-93.6x	-98.8x	219x	52.7x	23.2x
EV / FCF	-12.1x	-15.5x	23.2x	-46.6x	-	-344x	92.7x	44.5x
FCF Yield	-8.24%	-6.43%	4.31%	-2.15%	-	-0.29%	1.08%	2.24%
Dividend per Share ²	-	-	-	-	-	-	0.0169	0.2618
Rate of return	-	-	-	-	-	-	0.01%	0.23%
EPS ²	-1.32	-1.42	2.42	-0.6	-1.23	0.1394	1.54	2.948
Distribution rate	-	-	-	-	-	-	1.1%	8.88%
Net sales ¹	225.6	837.7	4,526	2,124	3,056	5,161	7,647	10,914
EBITDA ¹	-1,302	-1,225	2,191	-364.3	-641.9	942.2	2,077	4,334
EBIT ¹	-1,351	-1,331	2,049	-558.2	-903.7	449.1	1,844	3,954
Net income ¹	-1,075	-1,168	2,028	-514.5	-1,113	184	1,448	3,155
Net Debt ¹	-1,792	-225.1	1,425	1,026	-4,282	-5,522	-6,631	-12,234
Reference price ²	27.70	38.04	42.12	57.04	101.54	112.79	112.79	112.79
Nbr of stocks (in thousands)	8,17,057	8,41,057	8,41,057	8,97,575	9,21,143	9,21,143	-	-
Announcement Date	30/03/22	15/03/23	18/03/24	30/03/25	26/03/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
AKESO, INC.	817.74x	19.27x	105.56x	-.--%	1.54TCr
ARGENX SE	28.75x	7.55x	22.58x	-.--%	5.07TCr
WUXI APPTEC CO., LTD.	18x	5.52x	12.07x	1.65%	4.86TCr
BIONTECH SE	-17.95x	3.48x	-6.34x	-.--%	2.36TCr
INSMED INCORPORATED	-38.59x	12.9x	-34.98x	-.--%	2.25TCr
WUXI BIOLOGICS (CAYMAN) INC.	21.67x	4.28x	11.11x	-.--%	1.75TCr
GENMAB A/S	22.82x	4.44x	14.61x	-.--%	1.61TCr
SUMMIT THERAPEUTICS INC.	-15.63x	4112.17x	-19.09x	-.--%	1.45TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-452.98x	32.5x	-2035.42x	-.--%	1.34TCr
EXELIXIS, INC.	15.74x	4.52x	10.59x	-.--%	1.25TCr
Average	39.96x	420.66x	-191.93x	0.17%	2.35TCr
Weighted average by Cap.	35.47x	262.12x	-104.50x	0.34%